Shares of Five Prime Therapeutics (NASDAQ: FPRX) are surging on Thursday after the announcement that drugmaker Amgen Inc (NASDAQ: AMGN) will pay about $1.9 billion in cash to acquire the company.
Amgen will pay $38 per share, representing a premium of nearly 79% on Five Prime’s closing price of $21.26 on the 3rd of March.
The deal gives Amgen access to Five Primes’ drug candidate Bemarituzumab, which is ready to enter a late-stage trial for treating advanced gastric cancer. In a placebo-controlled Phase 2 study, the drug provided positive data.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The company believes the drug could play a key role in other epithelial cancers, including lung, breast, ovarian and more.
Amgen’s acquisition of Five Prime also supports its international expansion strategy, and they expect to generate significant volume growth in the coming years.
Five Prime Therapeutics shares are trading 78% higher premarket at $37.86. Amgen shares are unmoved, gaining 0.34% to $224.70 per share.
